{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T19:55:15Z","timestamp":1784318115144,"version":"3.55.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,9,19]],"date-time":"2023-09-19T00:00:00Z","timestamp":1695081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,9,19]],"date-time":"2023-09-19T00:00:00Z","timestamp":1695081600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"National High-Level Hospital Clinical Research Funding","award":["No. 2022-PUMCH-B-083"],"award-info":[{"award-number":["No. 2022-PUMCH-B-083"]}]},{"name":"Chinese Academy of Medical Sciences (CAMS) Innovation Fund for Medical Sciences","award":["No. 2022-I2M-C&T-B-023"],"award-info":[{"award-number":["No. 2022-I2M-C&T-B-023"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Women's Health"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Struma ovarii (SO) is a rare tumor and may transform into ovarian strumal carcinoid (OSC) and\/or malignant struma ovarii (MSO), but the incidence, clinical characteristics, and survival outcomes have not been well defined.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We conducted a retrospective study of patients with ovarian strumal diseases treated in the our hospital between 1980 and 2022. Subgroup analyses of SO, OSC, and MSO were subsequently performed.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A total of 275 cases (2.14%) were identified in a cohort of 12,864 patients with ovarian teratomas, where SO, OSC, and MSO accounted for 83.3%, 12.0%, and 4.7% of cases, respectively. There were no significant differences in age, tumor sizes, elevated tumor markers, and ascites among the three subgroups. At initial treatment, all patients with SO or OSC had FIGO stage I disease except one SO patient presenting metastatic disease, ten patients had MSO confined to the ovary, whereas other three patients had metastatic diseases. Two patients with SO respectively relapsed at peritoneum and anterior mesorectum, while none of the OSC patients presented tumor recurrence or death despite different surgical procedures employed. The 5-year recurrence-free survival rate was 88.9%, and only one death occurred at 9.5 years after diagnosis in patients with MSO. Radioiodine therapy showed satisfactory therapeutic efficacy, but these patients showed poor responses to the chemotherapy.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>2.14% of ovarian teratoma could be classified as SO, of which 12.0% and 4.7% of SO may transform into OSC and MSO, repsectively. The survival outcomes were excellent even after SO transformed into OSC or MSO.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Synopsis<\/jats:title>\n                <jats:p>SO occupied 2.14% of ovarian teratoma, where 12.0% and 4.7% of SO may transform into OSC and MSO, respectively, and had excellent survival outcomes.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12905-023-02624-5","type":"journal-article","created":{"date-parts":[[2023,9,19]],"date-time":"2023-09-19T17:01:59Z","timestamp":1695142919000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Incidence, clinical\u00a0characteristics, and survival outcomes of ovarian strumal diseases: a retrospective cohort study"],"prefix":"10.1186","volume":"23","author":[{"given":"Sijian","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruping","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,19]]},"reference":[{"issue":"2","key":"2624_CR1","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1148\/radiographics.21.2.g01mr09475","volume":"21","author":"EK Outwater","year":"2001","unstructured":"Outwater EK, Siegelman ES, Hunt JL. Ovarian teratomas: tumor types and imaging characteristics. Radiographics. 2001;21(2):475\u201390.","journal-title":"Radiographics"},{"issue":"4","key":"2624_CR2","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1097\/00004347-199310000-00008","volume":"12","author":"K Devaney","year":"1993","unstructured":"Devaney K, Snyder R, Norris HJ, Tavassoli FA. Proliferative and histologically malignant struma ovarii: a clinicopathologic study of 54 cases. Int J Gynecol Pathol. 1993;12(4):333\u201343.","journal-title":"Int J Gynecol Pathol"},{"key":"2624_CR3","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.2147\/IJWH.S379128","volume":"14","author":"S Wang","year":"2022","unstructured":"Wang S, He X, Yang H, Chen L. Struma Ovarii Associated with Ascites and elevated CA125: two case reports and review of the literature. Int J Womens Health. 2022;14:1291\u20136.","journal-title":"Int J Womens Health"},{"issue":"2","key":"2624_CR4","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1002\/uog.5396","volume":"32","author":"L Savelli","year":"2008","unstructured":"Savelli L, Testa AC, Timmerman D, et al. Imaging of gynecological disease (4): clinical and ultrasound characteristics of struma ovarii. Ultrasound Obstet Gynecol. 2008;32(2):210\u20139.","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"5","key":"2624_CR5","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1007\/s00404-008-0794-1","volume":"279","author":"MP Mui","year":"2009","unstructured":"Mui MP, Tam KF, Tam FK, Ngan HY. Coexistence of struma ovarii with marked ascites and elevated CA-125 levels: case report and literature review. Arch Gynecol Obstet. 2009;279(5):753\u20137.","journal-title":"Arch Gynecol Obstet"},{"key":"2624_CR6","doi-asserted-by":"publisher","first-page":"871210","DOI":"10.3389\/fendo.2022.871210","volume":"13","author":"A Turla","year":"2022","unstructured":"Turla A, Zamparini M, Milione M, et al. Ovarian strumal carcinoid: Case Report, systematic literature review and pooled analysis. Front Endocrinol (Lausanne). 2022;13:871210.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"5","key":"2624_CR7","doi-asserted-by":"publisher","first-page":"786","DOI":"10.5858\/134.5.786","volume":"134","author":"X Zhang","year":"2010","unstructured":"Zhang X, Axiotis C. Thyroid-type carcinoma of struma ovarii. Arch Pathol Lab Med. 2010;134(5):786\u201391.","journal-title":"Arch Pathol Lab Med"},{"issue":"1","key":"2624_CR8","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1097\/PGP.0000000000000117","volume":"34","author":"KE Muller","year":"2015","unstructured":"Muller KE, Tafe LJ, Gonzalez JL, West LA, Schned AR. Ovarian strumal carcinoid producing peptide YY associated with severe constipation: a case report and review of the literature. Int J Gynecol Pathol. 2015;34(1):30\u20135.","journal-title":"Int J Gynecol Pathol"},{"issue":"4","key":"2624_CR9","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1089\/thy.2011.0162","volume":"22","author":"JL Marti","year":"2012","unstructured":"Marti JL, Clark VE, Harper H, et al. Optimal surgical management of well-differentiated thyroid cancer arising in struma ovarii: a series of 4 patients and a review of 53 reported cases. Thyroid. 2012;22(4):400\u20136.","journal-title":"Thyroid"},{"issue":"5","key":"2624_CR10","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1007\/s00261-011-9817-7","volume":"37","author":"T Ikeuchi","year":"2012","unstructured":"Ikeuchi T, Koyama T, Tamai K, et al. CT and MR features of struma ovarii. Abdom Imaging. 2012;37(5):904\u201310.","journal-title":"Abdom Imaging"},{"issue":"4","key":"2624_CR11","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1007\/s12022-015-9396-1","volume":"26","author":"S Wei","year":"2015","unstructured":"Wei S, Baloch ZW, LiVolsi VA. Pathology of Struma Ovarii: a report of 96 cases. Endocr Pathol. 2015;26(4):342\u20138.","journal-title":"Endocr Pathol"},{"issue":"9","key":"2624_CR12","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1002\/1097-0142(19801101)46:9<2019::AID-CNCR2820460921>3.0.CO;2-W","volume":"46","author":"SJ Robboy","year":"1980","unstructured":"Robboy SJ, Scully RE. Strumal carcinoid of the ovary: an analysis of 50 cases of a distinctive tumor composed of thyroid tissue and carcinoid. Cancer. 1980;46(9):2019\u201334.","journal-title":"Cancer"},{"issue":"2","key":"2624_CR13","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s12022-020-09608-3","volume":"31","author":"S Theurer","year":"2020","unstructured":"Theurer S, Ingenwerth M, Herold T, Herrmann K, Schmid KW. Immunohistochemical Profile and 47-Gene next-generation sequencing (NGS) solid Tumor Panel Analysis of a series of 13 Strumal Carcinoids. Endocr Pathol. 2020;31(2):101\u20137.","journal-title":"Endocr Pathol"},{"issue":"1","key":"2624_CR14","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1186\/s12885-022-10167-5","volume":"22","author":"S Li","year":"2022","unstructured":"Li S, Wang X, Sui X, et al. Clinical characteristics and survival outcomes in patients with ovarian strumal carcinoid. BMC Cancer. 2022;22(1):1090.","journal-title":"BMC Cancer"},{"key":"2624_CR15","doi-asserted-by":"publisher","first-page":"774691","DOI":"10.3389\/fmed.2021.774691","volume":"8","author":"S Li","year":"2021","unstructured":"Li S, Kong S, Wang X, et al. Survival outcomes and prognostic predictors in patients with malignant struma Ovarii. Front Med (Lausanne). 2021;8:774691.","journal-title":"Front Med (Lausanne)"},{"issue":"6","key":"2624_CR16","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1007\/s00404-019-05329-z","volume":"300","author":"MR Siegel","year":"2019","unstructured":"Siegel MR, Wolsky RJ, Alvarez EA, Mengesha BM. Struma ovarii with atypical features and synchronous primary thyroid cancer: a case report and review of the literature. Arch Gynecol Obstet. 2019;300(6):1693\u2013707.","journal-title":"Arch Gynecol Obstet"},{"issue":"1","key":"2624_CR17","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1080\/00313020601123979","volume":"39","author":"LM Roth","year":"2007","unstructured":"Roth LM, Talerman A. The enigma of struma ovarii. Pathology. 2007;39(1):139\u201346.","journal-title":"Pathology"},{"issue":"2","key":"2624_CR18","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1089\/thy.2014.0328","volume":"25","author":"P Goffredo","year":"2015","unstructured":"Goffredo P, Sawka AM, Pura J, et al. Malignant struma ovarii: a population-level analysis of a large series of 68 patients. Thyroid. 2015;25(2):211\u20135.","journal-title":"Thyroid"},{"issue":"1","key":"2624_CR19","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s13244-013-0303-3","volume":"5","author":"MI Dujardin","year":"2014","unstructured":"Dujardin MI, Sekhri P, Turnbull LW. Struma ovarii: role of imaging? Insights Imaging. 2014;5(1):41\u201351.","journal-title":"Insights Imaging"},{"issue":"5","key":"2624_CR20","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1007\/s00261-010-9664-y","volume":"36","author":"J Shen","year":"2011","unstructured":"Shen J, Xia X, Lin Y, Zhu W, Yuan J. Diagnosis of Struma ovarii with medical imaging. Abdom Imaging. 2011;36(5):627\u201331.","journal-title":"Abdom Imaging"},{"issue":"1","key":"2624_CR21","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s13048-018-0383-2","volume":"11","author":"S Fujiwara","year":"2018","unstructured":"Fujiwara S, Tsuyoshi H, Nishimura T, Takahashi N, Yoshida Y. Precise preoperative diagnosis of struma ovarii with pseudo-meigs\u2019 syndrome mimicking ovarian cancer with the combination of (131)I scintigraphy and (18)F-FDG PET: case report and review of the literature. J Ovarian Res. 2018;11(1):11.","journal-title":"J Ovarian Res"},{"key":"2624_CR22","doi-asserted-by":"crossref","unstructured":"Kong S, Sun J, Sui X et al. Clinical characteristics and survival outcomes in patients with primary ovarian carcinoid: a historical cohort study. Acta Obstet Gynecol Scand. 2023.","DOI":"10.1111\/aogs.14578"},{"issue":"3","key":"2624_CR23","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1111\/j.1447-0756.2010.01231.x","volume":"36","author":"T Kurabayashi","year":"2010","unstructured":"Kurabayashi T, Minamikawa T, Nishijima S, et al. Primary strumal carcinoid tumor of the ovary with multiple bone and breast metastases. J Obstet Gynaecol Res. 2010;36(3):567\u201371.","journal-title":"J Obstet Gynaecol Res"},{"issue":"3","key":"2624_CR24","doi-asserted-by":"publisher","first-page":"222","DOI":"10.3109\/01443615.2011.645921","volume":"32","author":"S Jean","year":"2012","unstructured":"Jean S, Tanyi JL, Montone K, et al. Papillary thyroid cancer arising in struma ovarii. J Obstet Gynaecol. 2012;32(3):222\u20136.","journal-title":"J Obstet Gynaecol"},{"issue":"3","key":"2624_CR25","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/S0090-8258(03)00141-0","volume":"89","author":"CP DeSimone","year":"2003","unstructured":"DeSimone CP, Lele SM, Modesitt SC. Malignant struma ovarii: a case report and analysis of cases reported in the literature with focus on survival and I131 therapy. Gynecol Oncol. 2003;89(3):543\u20138.","journal-title":"Gynecol Oncol"},{"issue":"4","key":"2624_CR26","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1111\/j.1754-9485.2012.02394.x","volume":"56","author":"RK Shrimali","year":"2012","unstructured":"Shrimali RK, Shaikh G, Reed NS. Malignant struma ovarii: the west of Scotland experience and review of literature with focus on postoperative management. J Med Imaging Radiat Oncol. 2012;56(4):478\u201382.","journal-title":"J Med Imaging Radiat Oncol"},{"issue":"1","key":"2624_CR27","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1186\/s12885-021-08118-7","volume":"21","author":"S Li","year":"2021","unstructured":"Li S, Yang T, Xiang Y, et al. Clinical characteristics and survival outcomes of malignant struma ovarii confined to the ovary. BMC Cancer. 2021;21(1):383.","journal-title":"BMC Cancer"},{"issue":"2","key":"2624_CR28","doi-asserted-by":"publisher","first-page":"167","DOI":"10.4158\/EP.15.2.167","volume":"15","author":"JF McGill","year":"2009","unstructured":"McGill JF, Sturgeon C, Angelos P. Metastatic struma ovarii treated with total thyroidectomy and radioiodine ablation. Endocr Pract. 2009;15(2):167\u201373.","journal-title":"Endocr Pract"},{"key":"2624_CR29","doi-asserted-by":"publisher","first-page":"584917","DOI":"10.3389\/fonc.2020.584917","volume":"10","author":"S Li","year":"2020","unstructured":"Li S, Yang T, Li X, et al. FIGO Stage IV and Age over 55 years as prognostic predicators in patients with metastatic malignant struma Ovarii. Front Oncol. 2020;10:584917.","journal-title":"Front Oncol"},{"issue":"10","key":"2624_CR30","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1016\/j.clon.2006.09.002","volume":"18","author":"JM Zekri","year":"2006","unstructured":"Zekri JM, Manifold IH, Wadsley JC. Metastatic struma ovarii: late presentation, unusual features and multiple radioactive iodine treatments. Clin Oncol (R Coll Radiol). 2006;18(10):768\u201372.","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"2624_CR31","first-page":"147","volume":"2","author":"EW Janszen","year":"2008","unstructured":"Janszen EW, van Doorn HC, Ewing PC, et al. Malignant struma ovarii: good response after thyroidectomy and I ablation therapy. Clin Med Oncol. 2008;2:147\u201352.","journal-title":"Clin Med Oncol"},{"issue":"5","key":"2624_CR32","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1097\/PGP.0000000000000178","volume":"34","author":"H Cong","year":"2015","unstructured":"Cong H, Li T, Chen G, et al. Missed initial diagnosis of Malignant Struma Ovarii containing follicular thyroid carcinoma: metastatic pulmonary recurrence 17 year after Ovariectomy. Int J Gynecol Pathol. 2015;34(5):445\u20139.","journal-title":"Int J Gynecol Pathol"},{"key":"2624_CR33","first-page":"7964126","volume":"2019","author":"EG Tzelepis","year":"2019","unstructured":"Tzelepis EG, Barengolts E, Garzon S, Shulan J, Eisenberg Y. Unusual case of malignant struma Ovarii and cervical thyroid Cancer preceded by ovarian teratoma: Case Report and Review of the literature. Case Rep Endocrinol. 2019;2019:7964126.","journal-title":"Case Rep Endocrinol"},{"issue":"4","key":"2624_CR34","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1089\/thy.2019.0504","volume":"30","author":"EFS van Velsen","year":"2020","unstructured":"van Velsen EFS, Visser WE, van den Berg SAA, et al. Longitudinal analysis of the Effect of Radioiodine Therapy on Ovarian Reserve in females with differentiated thyroid Cancer. Thyroid. 2020;30(4):580\u20137.","journal-title":"Thyroid"},{"issue":"6","key":"2624_CR35","doi-asserted-by":"publisher","first-page":"2458","DOI":"10.3892\/ol.2014.2587","volume":"8","author":"M Ukita","year":"2014","unstructured":"Ukita M, Nakai H, Kotani Y, et al. Long-term survival in metastatic malignant struma ovarii treated with oral chemotherapy: a case report. Oncol Lett. 2014;8(6):2458\u201362.","journal-title":"Oncol Lett"}],"container-title":["BMC Women's Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-023-02624-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12905-023-02624-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-023-02624-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,21]],"date-time":"2023-11-21T07:04:25Z","timestamp":1700550265000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcwomenshealth.biomedcentral.com\/articles\/10.1186\/s12905-023-02624-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,19]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2624"],"URL":"https:\/\/doi.org\/10.1186\/s12905-023-02624-5","relation":{},"ISSN":["1472-6874"],"issn-type":[{"value":"1472-6874","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,19]]},"assertion":[{"value":"30 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This retrospective study was approved by the Ethics Committee of Peking Union Medical College Hospital (reference number: S-K1198) and all methods were carried out by the Declaration of Helsinki. Written informed consent to participate in the study was waived by the Peking Union Medical College Hospital ethics committee due to the retrospective nature of the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"497"}}